{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:56:59Z","timestamp":1792792619708,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.resmer.2025.101157","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:01:25Z","timestamp":1738353685000},"page":"101157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Long-acting muscarinic antagonists (LAMA) in asthma: What is the best strategy?"],"prefix":"10.1016","volume":"87","author":[{"given":"Guillaume","family":"Mahay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Zysman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Guibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Barnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Guilleminault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clairelyne","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.resmer.2025.101157_bib0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/pr.111.004580","article-title":"Pharmacology and therapeutics of bronchodilators","volume":"64","author":"Cazzola","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.resmer.2025.101157_bib0002","first-page":"21","article-title":"Physiology of the parasympathetic nervous system of the lung","volume":"63","author":"Sheppard","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.resmer.2025.101157_bib0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-444-53491-0.00018-3","article-title":"Autonomic neural control of the airways","volume":"117","author":"Mazzone","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.resmer.2025.101157_bib0004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaci.2022.06.015","article-title":"Optimizing asthma management: role of long-acting muscarinic antagonists","volume":"150","author":"Casale","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.resmer.2025.101157_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pupt.2004.03.001","article-title":"The airway cholinergic system: physiology and pharmacology","volume":"17","author":"Rack\u00e9","year":"2004","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resmer.2025.101157_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2021.01.027","article-title":"Inhaled long-acting muscarinic antagonists in asthma - A narrative review","volume":"85","author":"Papi","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.resmer.2025.101157_bib0007","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1681.1990.tb01287.x","article-title":"Effect of acetylcholine and morphine on bronchial smooth muscle contraction and its modulation by steroid hormones","volume":"17","author":"Nabishah","year":"1990","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4 Pt 1)","key":"10.1016\/j.resmer.2025.101157_bib0008","first-page":"L745","article-title":"Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle","volume":"272","author":"Emala","year":"1997","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.resmer.2025.101157_bib0009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1165\/ajrcmb.24.4.4379","article-title":"Glucocorticoid treatment increases inhibitory m(2) muscarinic receptor expression and function in the airways","volume":"24","author":"Jacoby","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resmer.2025.101157_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2015.11.004","article-title":"Interaction between corticosteroids and muscarinic antagonists in human airways","volume":"36","author":"Cazzola","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.resmer.2025.101157_bib0011","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bph.14909","article-title":"Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo","volume":"177","author":"Rogliani","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.resmer.2025.101157_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114112","article-title":"ROS responsive hydrogel for inhibition of MUC5AC against allergic rhinitis: a new delivery strategy for ipratropium bromide","volume":"242","author":"Zhao","year":"2024","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.resmer.2025.101157_bib0013","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Updated May 2023. Available on: https:\/\/ginasthma.org\/wp-content\/uploads\/2023\/05\/GINA-2023-Full-Report-2023-WMS.pdf."},{"key":"10.1016\/j.resmer.2025.101157_bib0014","unstructured":"National Heart, Lung, and Blood Institute. 2020 Focused updates to the Asthma Management Guidelines: At-a-glance guide. U.S. Department of Health and Human Services; 2020."},{"issue":"10","key":"10.1016\/j.resmer.2025.101157_bib0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.rmr.2021.08.002","volume":"38","author":"Raherison-Semjen","year":"2021","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.resmer.2025.101157_bib0016","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). (2024). Base de donn\u00e9es publique des m\u00e9dicaments. Available from: https:\/\/base-donnees-publique.medicaments.gouv.fr."},{"issue":"13","key":"10.1016\/j.resmer.2025.101157_bib0017","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.resmer.2025.101157_bib0018","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2025.101157_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106021","article-title":"Fixed-dose combination of indacaterol\/glycopyrronium\/mometasone furoate once-daily versus salmeterol\/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: a randomised, phase IIIb, non-inferiority study (ARGON)","volume":"170","author":"Gessner","year":"2020","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10210","key":"10.1016\/j.resmer.2025.101157_bib0021","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.resmer.2025.101157_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium respimat\u00ae is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12931-020-01349-5","article-title":"Letter to the editor: indacaterol\/glycopyrronium\/mometasone furoate compared with salmeterol\/fluticasone propionate in patients with asthma: a randomized controlled cross-over study","volume":"21","author":"Watz","year":"2020","journal-title":"Respir Res"},{"issue":"12","key":"10.1016\/j.resmer.2025.101157_bib0024","article-title":"Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis","volume":"12","author":"Oba","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resmer.2025.101157_bib0026","first-page":"944","article-title":"Therapeutic effects of a long-acting cholinergic receptor blocker, tiotropium bromide, on asthma","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit Int Med J Exp Clin Res."},{"issue":"5","key":"10.1016\/j.resmer.2025.101157_bib0027","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2013.08.003","article-title":"Predictors of response to tiotropium versus salmeterol in asthmatic adults","volume":"132","author":"Peters","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.resmer.2025.101157_bib0028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.resmer.2025.101157_bib0029","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/1440-1681.12239","article-title":"Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial","volume":"41","author":"Rajanandh","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"12","key":"10.1016\/j.resmer.2025.101157_bib0030","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.09-0011","article-title":"Cardiovascular safety of tiotropium in patients with COPD","volume":"137","author":"Celli","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.resmer.2025.101157_bib0032","article-title":"Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease","volume":"6","author":"Fukuda","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.resmer.2025.101157_bib0033","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jaip.2020.04.013","article-title":"Tiotropium respimat efficacy and safety in asthma: relationship to age","volume":"8","author":"Doherty","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.resmer.2025.101157_bib0034","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04233-2020","article-title":"Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies","volume":"58","author":"Rogliani","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101157_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618824010","article-title":"Safety of tiotropium in patients with asthma","volume":"13","author":"Dusser","year":"2019","journal-title":"Ther Adv Respir Dis"},{"issue":"11","key":"10.1016\/j.resmer.2025.101157_bib0036","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.jaip.2022.06.010","article-title":"Adherence and persistence to single-inhaler versus multiple-inhaler triple therapy for asthma management","volume":"10","author":"Busse","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"143","key":"10.1016\/j.resmer.2025.101157_bib0037","article-title":"Personalised medicine in asthma: from curative to preventive medicine","volume":"26","author":"Guilleminault","year":"2017","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"issue":"3","key":"10.1016\/j.resmer.2025.101157_bib0038","doi-asserted-by":"crossref","first-page":"00013","DOI":"10.1183\/23120541.00013-2018","article-title":"Understanding asthma phenotypes: the World Asthma Phenotypes (WASP) international collaboration","volume":"4","author":"Pembrey","year":"2018","journal-title":"ERJ Open Res"},{"issue":"5","key":"10.1016\/j.resmer.2025.101157_bib0039","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.resmer.2025.101157_bib0040","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2021.7872","article-title":"Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis","volume":"325","author":"Kim","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0041","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12931-020-01558-y","article-title":"Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER","volume":"21","author":"Singh","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.resmer.2025.101157_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107334","article-title":"Efficacy of mometasone\/indacaterol\/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: post hoc analysis of IRIDIUM study","volume":"217","author":"Kostikas","year":"2023","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2213-2600(22)00185-0","article-title":"Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study","volume":"11","author":"Kole","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.resmer.2025.101157_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00476-2020","article-title":"Extrafine triple therapy in patients with asthma and persistent airflow limitation","volume":"56","author":"Singh","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2021.01.007","article-title":"Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses","volume":"148","author":"Papi","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resmer.2025.101157_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107172","article-title":"Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone\/indacaterol\/glycopyrronium in patients with asthma with or without persistent airflow limitation: post hoc analysis from the IRIDIUM study","volume":"211","author":"Van Zyl-Smit","year":"2023","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0047","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1164\/rccm.202210-2005OC","article-title":"Efficacy of Tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials","volume":"208","author":"Corren","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.resmer.2025.101157_bib0048","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cea.13614","article-title":"Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort","volume":"50","author":"Dupin","year":"2020","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.resmer.2025.101157_bib0049","first-page":"1237","article-title":"Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma","volume":"59","author":"Spain","year":"2022","journal-title":"J Asthma Off J Assoc Care Asthma"},{"issue":"2","key":"10.1016\/j.resmer.2025.101157_bib0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.resmer.2025.101157_bib0051","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.resmer.2025.101157_bib0052","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2018.2757","article-title":"Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.resmer.2025.101157_bib0053","article-title":"Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA\/ICS) versus LABA\/ICS for adults with asthma","volume":"2016","author":"Kew","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10423","key":"10.1016\/j.resmer.2025.101157_bib0054","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet Lond Engl"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:34:18Z","timestamp":1748504058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":54,"alternative-id":["S2590041225000042"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101157","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting muscarinic antagonists (LAMA) in asthma: What is the best strategy?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101157"}}